Antibody diluent for IHC is developed for dilution of primary antibodies in immunohistochemical applications. The product includes a background reducing agent assisting to prevent non-specific binding and to reduce background staining. Main components are: TRIS, TRIS-HCl, < 0.1 % sodium azide, regular sera.